Board Member
Pulse Biosciences, Inc. (PLSE)Equibles does not estimate personal net worth.
Get an email with a short summary when Pulse Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get PLSE alertsBurke T. Barrett is recorded as Board Member and CEO at Pulse Biosciences, Inc. (PLSE) since May 12, 2024. Pulse Biosciences, Inc. reported in an 8-K filed December 6, 2024 that Burke T. Barrett resigned as Board of Directors, effective December 2, 2024. Pulse Biosciences, Inc. reported in an 8-K filed December 6, 2024 that Burke T. Barrett resigned as President and Chief Executive Officer, effective December 6, 2024. Pulse Biosciences, Inc. reported in an 8-K filed May 15, 2024 that Burke T. Barrett was appointed President and Chief Executive Officer. Equibles holds 6 filed executive changes naming Burke T. Barrett; each is listed under recent activity with its source filing. The proxy statement of Pulse Biosciences, Inc. reports total compensation of $8,435,605 for Burke T. Barrett in fiscal 2024, including a base salary of $327,318. Disclosed compensation is on record for 4 fiscal years. Burke T. Barrett has spoken on 2 earnings calls across 1 company, most recently for Pulse Biosciences, Inc. on October 30, 2024. Pulse Biosciences, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Pulse Biosciences, Inc. includes Kevin Danahy (CEO), Paul A. LaViolette (CEO, Chairman and Board Member), Paul LaViolette (CEO and Board Member) and 7 others.
“In addition, Mr. Barrett resigned from the Company's Board of Directors effective as of December 2, 2024.”
“On December 2, 2024, Pulse Biosciences, Inc. (the "Company") and Mr. Burke T. Barrett, President and Chief Executive Officer, agreed that he would resign from the Company, effective as of December 6, 2024 (the "Separation Date").”
“Today, I will start by providing updates on our business progress, and then Mike Koffler, Vice President of Finance, will review the third quarter 2024 financial results.”
“I'm glad to be on my first Pulse Biosciences earnings call since being appointed President and CEO of Pulse in May of this year. Today, I'll provide updates on our continued business progress and then Michael Koffler, Vice President of Finance will review certain second quarter 2024 financial results.”
2024-05-12–present
2024-05-12–present
2024-05-12–2024-12-06
2024-05-12–2024-12-02
Start not stated–2024-12-06
Medical Instruments & Supplies · Healthcare
Board Member, CEO
2024-05-12–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Pulse Biosciences, Inc. (PLSE) | Former Chief Executive Officer and Former Director | — | — |
| 2024 | Pulse Biosciences, Inc. (PLSE) | Former Chief Executive Officer and Director | $327,318 | $8,435,605 |
| 2023 | Pulse Biosciences, Inc. (PLSE) | Former Chief Executive Officer and Director | — | — |
| 2022 | Pulse Biosciences, Inc. (PLSE) | Former Chief Executive Officer and Former Director | — | — |
